Mitchell R Dyer1, Wyeth Alexander2, Adnan Hassoune1, Qiwei Chen1, Tomasz Brzoska3, Jurgis Alvikas1, Yingjie Liu1, Shannon Haldeman1, Will Plautz2, Patricia Loughran1,4, Hui Li5,6, Brian Boone1, Yoel Sadovsky5, Prithu Sundd3, Brian S Zuckerbraun1, Matthew D Neal1. 1. Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 2. University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 3. Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 4. Center for Biological Imaging, University of Pittsburgh, Pittsburgh, Pennsylvania. 5. Department of Obstetrics, Gynecology, and Reproductive Science, Magee-Women's Research Institute, Pittsburgh, Pennsylvania. 6. Xiangya School of Medicine, Central South University, Changsha, China.
Abstract
BACKGROUND: Traumatic injury can lead to dysregulation of the normal clotting system, resulting in hemorrhagic and thrombotic complications. Platelet activation is robust following traumatic injury and one process of platelet activation is to release of extracellular vesicles (PEV) that carry heterogenous cargo loads and surface ligands. OBJECTIVES: We sought to investigate and characterize the release and function of PEVs generated following traumatic injury. METHODS: PEV content and quantity in circulation following trauma in humans and mice was measured using flow cytometry, size exclusion chromatography, and nanoparticle tracking analysis. PEVs were isolated from circulation and the effects on thrombin generation, bleeding time, hemorrhage control, and thrombus formation were determined. Finally, the effect of hydroxychloroquine (HCQ) on PEV release and thrombosis were examined. RESULTS: Human and murine trauma results in a significant release of PEVs into circulation compared with healthy controls. These PEVs result in abundant thrombin generation, increased platelet aggregation, decreased bleeding times, and decreased hemorrhage in uncontrolled bleeding. Conversely, PEVs contributed to enhanced venous thrombus formation and were recruited to the developing thrombus site. Interestingly, HCQ treatment resulted in decreased platelet aggregation, decreased PEV release, and reduced deep vein thrombosis burden in mice. CONCLUSIONS: These data demonstrate that trauma results in significant release of PEVs which are both pro-hemostatic and pro-thrombotic. The effects of PEVs can be mitigated by treatment with HCQ, suggesting the potential use as a form of deep vein thrombosis prophylaxis.
BACKGROUND:Traumatic injury can lead to dysregulation of the normal clotting system, resulting in hemorrhagic and thrombotic complications. Platelet activation is robust following traumatic injury and one process of platelet activation is to release of extracellular vesicles (PEV) that carry heterogenous cargo loads and surface ligands. OBJECTIVES: We sought to investigate and characterize the release and function of PEVs generated following traumatic injury. METHODS: PEV content and quantity in circulation following trauma in humans and mice was measured using flow cytometry, size exclusion chromatography, and nanoparticle tracking analysis. PEVs were isolated from circulation and the effects on thrombin generation, bleeding time, hemorrhage control, and thrombus formation were determined. Finally, the effect of hydroxychloroquine (HCQ) on PEV release and thrombosis were examined. RESULTS:Human and murinetrauma results in a significant release of PEVs into circulation compared with healthy controls. These PEVs result in abundant thrombin generation, increased platelet aggregation, decreased bleeding times, and decreased hemorrhage in uncontrolled bleeding. Conversely, PEVs contributed to enhanced venous thrombus formation and were recruited to the developing thrombus site. Interestingly, HCQ treatment resulted in decreased platelet aggregation, decreased PEV release, and reduced deep vein thrombosis burden in mice. CONCLUSIONS: These data demonstrate that trauma results in significant release of PEVs which are both pro-hemostatic and pro-thrombotic. The effects of PEVs can be mitigated by treatment with HCQ, suggesting the potential use as a form of deep vein thrombosis prophylaxis.
Authors: Jose A Diaz; Andrea T Obi; Daniel D Myers; Shirley K Wrobleski; Peter K Henke; Nigel Mackman; Thomas W Wakefield Journal: Arterioscler Thromb Vasc Biol Date: 2012-03 Impact factor: 8.311
Authors: Julio A Chirinos; Gustavo A Heresi; Hermes Velasquez; Wenche Jy; Joaquin J Jimenez; Eugene Ahn; Lawrence L Horstman; Andres O Soriano; Juan P Zambrano; Yeon S Ahn Journal: J Am Coll Cardiol Date: 2005-05-03 Impact factor: 24.094
Authors: Carolina E Touw; Banne Nemeth; Willem M Lijfering; Raymond A van Adrichem; Line Wilsgård; Nadezhda Latysheva; Cathrine Ramberg; Rob G H H Nelissen; John-Bjarne Hansen; Suzanne C Cannegieter Journal: Res Pract Thromb Haemost Date: 2022-06-08
Authors: Zachary A Matthay; Zane J Hellmann; Brenda Nunez-Garcia; Alexander T Fields; Joseph Cuschieri; Matthew D Neal; Jeffrey S Berger; Elliot Luttrell-Williams; M Margaret Knudson; Mitchell J Cohen; Rachael A Callcut; Lucy Z Kornblith Journal: J Trauma Acute Care Surg Date: 2022-04-21 Impact factor: 3.697
Authors: Paul Vulliamy; Lucy Z Kornblith; Matthew E Kutcher; Mitchell J Cohen; Karim Brohi; Matthew D Neal Journal: Platelets Date: 2020-01-27 Impact factor: 3.862
Authors: Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia Journal: Nat Rev Dis Primers Date: 2021-04-29 Impact factor: 65.038
Authors: Julia R Coleman; Ernest E Moore; Jason M Samuels; Mitchell J Cohen; Christopher C Silliman; Arsen Ghasabyan; James Chandler; Saulius Butenas Journal: J Am Coll Surg Date: 2021-02-04 Impact factor: 6.532
Authors: William E Plautz; Shannon H Haldeman; Mitchell R Dyer; Jason L Sperry; Francis X Guyette; Patricia A Loughran; Jurgis Alvikas; Adnan Hassoune; Lara Hoteit; Nijmeh Alsaadi; Brian S Zuckerbraun; Marian A Rollins-Raval; Jay S Raval; Roberto I Mota; Matthew D Neal Journal: Blood Coagul Fibrinolysis Date: 2022-01-01 Impact factor: 1.061